Benzyl 4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidin-1-yl]-(4-methylpiperazin-1-yl)methanone;4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-1-piperidin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]morpholine
C80H88F6N26O6 — CID 162112563
Data last refreshed: (MolForge compound catalog, from PubChem)
About Benzyl 4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidin-1-yl]-(4-methylpiperazin-1-yl)methanone;4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-1-piperidin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]morpholine
Benzyl 4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidin-1-yl]-(4-methylpiperazin-1-yl)methanone;4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-1-piperidin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]morpholine (PubChem CID 162112563) has the molecular formula C80H88F6N26O6 and a molecular weight of 1623.75 g/mol. Its IUPAC name is benzyl 4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidin-1-yl]-(4-methylpiperazin-1-yl)methanone;4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-1-piperidin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]morpholine.
Molecular Properties
| Compound Name | Benzyl 4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidin-1-yl]-(4-methylpiperazin-1-yl)methanone;4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-1-piperidin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]morpholine |
|---|---|
| PubChem CID | 162112563 |
| Molecular Formula | C80H88F6N26O6 |
| Molecular Weight | 1623.75 g/mol |
| Exact Mass | 1622.73 |
| IUPAC Name | benzyl 4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-1-yl]piperidin-1-yl]-(4-methylpiperazin-1-yl)methanone;4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-1-piperidin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]morpholine |
| SMILES | CN1CCN(C(=O)N2CCC(n3ncc4c(-n5c(C(F)F)nc6ccccc65)nc(N5CCOCC5)nc43)CC2)CC1.FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc2c1cnn2C1CCNCC1.O=C(OCc1ccccc1)N1CCC(n2ncc3c(-n4c(C(F)F)nc5ccccc54)nc(N4CCOCC4)nc32)CC1 |
| InChI | InChI=1S/C30H30F2N8O3.C28H34F2N10O2.C22H24F2N8O/c31-25(32)28-34-23-8-4-5-9-24(23)39(28)26-22-18-33-40(27(22)36-29(35-26)37-14-16-42-17-15-37)21-10-12-38(13-11-21)30(41)43-19-20-6-2-1-3-7-20;1-35-10-12-38(13-11-35)28(41)37-8-6-19(7-9-37)40-25-20(18-31-40)24(33-27(34-25)36-14-16-42-17-15-36)39-22-5-3-2-4-21(22)32-26(39)23(29)30;23-18(24)21-27-16-3-1-2-4-17(16)31(21)19-15-13-26-32(14-5-7-25-8-6-14)20(15)29-22(28-19)30-9-11-33-12-10-30/h1-9,18,21,25H,10-17,19H2;2-5,18-19,23H,6-17H2,1H3;1-4,13-14,18,25H,5-12H2 |
| InChIKey | ZGINWMMBWLJCAA-UHFFFAOYSA-N |
| XLogP | 10.72 |
| TPSA | 290.03 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 118 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1623.75 |
| LogP ≤ 5 | 10.72 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 29 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162112563 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.